Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05797662 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Propranolol to Treat Kaposi Sarcoma

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 6 more changesShow less
    • Primary completion moved earlier from Apr 2029 to Sep 2028
    • Study completion date: Apr 2029 to Mar 2029
    • Start date changed from estimate of Sep 2026 to Aug 31, 2026
    • Eligibility criteria expanded, about 27 words
    • Secondary endpoints: details revised at 6 of 7 entries
    • Site details revised at 6 of 6 sites
  2. Trial sites reduced: 9 → 6 locationsv8
  3. Primary and study completion dates: Jun 2027 to Apr 2029
    • Start date: Jun 2026 to Sep 2026
    v7
  4. Primary completion date: Aug 1, 2028 to Jun 2027
    • Start date: Sep 2025 to Jun 2026
    • Study completion date: Aug 1, 2029 to Jun 2027
    v6
  5. Start date: Jul 1, 2025 to Sep 2025v5
Show 3 earlier versionsHide 3 earlier versions
  1. Re-verified, no change to tracked fieldsv4
  2. Primary completion date: Aug 1, 2026 to Aug 1, 2028
    • Start date: Jul 1, 2024 to Jul 1, 2025
    • Study completion date: Aug 1, 2028 to Aug 1, 2029
    v3
  3. Eligibility criteria expanded, about 36 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A clinical study of propranolol for the treatment of Kaposi Sarcoma in children and adults. This study will be an open-label single armed treatment trial that will test the effectiveness and the safety of treating Kaposi Sarcoma with propranolol.
Trial Details
NCT Number NCT05797662
Lead Sponsor AIDS Malignancy Consortium
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Kaposi Sarcoma
Related terms Sarcoma, Kaposi
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov